603
Views
34
CrossRef citations to date
0
Altmetric
Review Article

Assaying embryotoxicity in the test tube: Current limitations of the embryonic stem cell test (EST) challenging its applicability domain

, , , , , & show all
Pages 443-464 | Received 16 Nov 2011, Accepted 07 Mar 2012, Published online: 18 Apr 2012

References

  • Adler M, Müller K, Rached E, Dekant W, Mally A. (2009). Modulation of key regulators of mitosis linked to chromosomal instability is an early event in ochratoxin A carcinogenicity. Carcinogenesis 30:711–719.
  • Aidlen JT, Nazarey PP, Kinane TB, Donahoe PK, Schnitzer JJ, Kling DE. (2007). Retinoic acid-mediated differentiation protects against nitrofen-induced apoptosis. Birth Defects Res B Dev Reprod Toxicol 80:406–416.
  • Alves ALG, Rodrigues MAM, Aguiar AJA, Thomassian A, Nicoletti JLM, Hussni CA, Borges AS. (2001). Effects of beta-aminopropionitrile fumarate and exercise on equine tendon healing: Gross and histological aspects. J Equine Vet Sci 21, 335–340.
  • Augustine-Rauch K, Zhang CX, Panzica-Kelly JM. (2010). In vitro developmental toxicology assays: A review of the state of the science of rodent and zebrafish whole embryo culture and embryonic stem cell assays. Birth Defects Res C Embryo Today 90:87–98.
  • Bakke OM, Segura J. (1976). The absorption and elimination of metoclopramide in three animal species. J Pharm Pharmacol 28:32–39.
  • Baldacci A, Prost F, Thormann W. (2004). Identification of diphenhydramine metabolites in human urine by capillary electrophoresis-ion trap-mass spectrometry. Electrophoresis 25:1607–1614.
  • Balls M, Blaauboer BJ, Fentem JH, Bruner L, Combes RD, Ekwall B, Fielder RJ, Guillouzo A, Lewis RW, Lovell DP, Reinhardt CA, Repetto G, Sladowski D, Spielmann H, Zucco F. (1995). Practical aspects of the validation of toxicity test procedures. The report and recommendations of ECVAM workshop 5. Altern Lab Anim 23, 129–147.
  • Bassanini S, Hallene K, Battaglia G, Finardi A, Santaguida S, Cipolla M, Janigro D. (2007). Early cerebrovascular and parenchymal events following prenatal exposure to the putative neurotoxin methylazoxymethanol. Neurobiol Dis 26:481–495.
  • Becker M, Nothwang HG, Friauf E. (2003). Differential expression pattern of chloride transporters NCC, NKCC2, KCC1, KCC3, KCC4, and AE3 in the developing rat auditory brainstem. Cell Tissue Res 312:155–165.
  • Bejar A, Roujansky P, de Barry J, Gombos G. (1985). Different effect of methylazoxymethanol on mouse cerebellar development depending on the age of injection. Exp Brain Res 57:279–285.
  • Belpaire FM, Bogaert MG. (1975). Metabolism of papaverine. II. Species differences. Xenobiotica 5:421–429.
  • Belpaire FM, Bogaert MG, Rosseel MT, Anteunis M. (1975). Metabolism of papaverine. I. Identification of metabolites in rat bile. Xenobiotica 5:413–420.
  • Berkner KL. (2005). The vitamin K-dependent carboxylase. Annu Rev Nutr 25:127–149.
  • Bishai R, Mazzotta P, Atanackovic G, Levichek Z, Pole M, Magee LA, Koren G. (2000). Critical appraisal of drug therapy for nausea and vomiting of pregnancy: II. Efficacy and safety of diclectin (doxylamine-B6). Can J Clin Pharmacol 7:138–143.
  • Blaesse P, Airaksinen MS, Rivera C, Kaila K. (2009). Cation-chloride cotransporters and neuronal function. Neuron 61:820–838.
  • Bose-O’Reilly S, McCarty KM, Steckling N, Lettmeier B. (2010). Mercury exposure and children’s health. Curr Probl Pediatr Adolesc Health Care 40:186–215.
  • Brent R. (2003). Bendectin and birth defects: hopefully, the final chapter. Birth Defects Res Part A Clin Mol Teratol 67:79–87.
  • Brent RL. (1995). Bendectin: review of the medical literature of a comprehensively studied human nonteratogen and the most prevalent tortogen-litigen. Reprod Toxicol 9:337–349.
  • Brewer GJ. (2006). Novel therapeutic approaches to the treatment of Wilson’s disease. Expert Opin Pharmacother 7:317–324.
  • Bridges CC, Zalups RK. (2010). Transport of inorganic mercury and methylmercury in target tissues and organs. J Toxicol Environ Health B Crit Rev 13:385–410.
  • Brielmeier M, Béchet JM, Falk MH, Pawlita M, Polack A, Bornkamm GW. (1998). Improving stable transfection efficiency: antioxidants dramatically improve the outgrowth of clones under dominant marker selection. Nucleic Acids Res 26:2082–2085.
  • Brown BB, Werner HW. (1948). The pharmacologic properties of 2-[alpha-(2-dimethylaminoethoxy)-alpha-methylbenzyl]-pyridine succinate, a new antihistaminic agent. J Lab Clin Med 33:325–331.
  • Brown NA. (2002). Selection of test chemicals for the ECVAM international validation study on in vitro embryotoxicity tests. European Centre for the Validation of Alternative Methods. Altern Lab Anim 30:177–198.
  • Brown TJ, Manson JM. (1986). Further characterization of the distribution and metabolism of nitrofen in the pregnant rat. Teratology 34:129–139.
  • Bucher JR. (1989). Toxicology and Carcinogenesis Studies of Furosemide (CAS No. 54-31-9) in F344/N Rats and B6C3F1 Mice (Feed Studies). Natl Toxicol Program Tech Rep Ser 356, 1–190.
  • Buesen R, Genschow E, Slawik B, Visan A, Spielmann H, Luch A, Seiler A. (2009). Embryonic stem cell test remastered: comparison between the validated EST and the new molecular FACS-EST for assessing developmental toxicity in vitro. Toxicol Sci 108:389–400.
  • Buesen R, Visan A, Genschow E, Slawik B, Spielmann H, Seiler A. (2004). Trends in improving the embryonic stem cell test (EST): an overview. ALTEX 21:15–22.
  • Carney EW, Kimmel CA. (2007). Interpretation of skeletal variations for human risk assessment: delayed ossification and wavy ribs. Birth Defects Res B Dev Reprod Toxicol 80:473–496.
  • Carota I, Theilig F, Oppermann M, Kongsuphol P, Rosenauer A, Schreiber R, Jensen BL, Walter S, Kunzelmann K, Castrop H. (2010). Localization and functional characterization of the human NKCC2 isoforms. Acta Physiol (Oxf) 199:327–338.
  • Casas López JL, Sánchez Pérez JA, Fernández Sevilla JM, Acién Fernández FG, Molina Grima E, Chisti Y. (2003). Production of lovastatin by Aspergillus terreus: effects of the C: N ratio and the principal nutrients on growth and metabolite production. Enzyme Microb Tech 33, 270–277.
  • Cattabeni F, Di Luca M. (1997). Developmental models of brain dysfunctions induced by targeted cellular ablations with methylazoxymethanol. Physiol Rev 77:199–215.
  • Cavallotti C, Mancone M, Bruzzone P, Sabbatini M, Mignini F. (2010). Dopamine receptor subtypes in the native human heart. Heart Vessels 25:432–437.
  • Cecchelli R, Berezowski V, Lundquist S, Culot M, Renftel M, Dehouck MP, Fenart L. (2007). Modelling of the blood-brain barrier in drug discovery and development. Nat Rev Drug Discov 6:650–661.
  • Choi BH. (1986). Methylmercury poisoning of the developing nervous system: I. Pattern of neuronal migration in the cerebral cortex. Neurotoxicology 7:591–600.
  • Choi BH, Lapham LW, Amin-Zaki L, Saleem T. (1978). Abnormal neuronal migration, deranged cerebral cortical organization, and diffuse white matter astrocytosis of human fetal brain: a major effect of methylmercury poisoning in utero. J Neuropathol Exp Neurol 37:719–733.
  • Cirillo VJ, Tempero KF. (1976). Pharmacology and therapeutic use of antihistamines. Am J Hosp Pharm 33:1200–1207.
  • Coecke S, Ahr H, Blaauboer BJ, Bremer S, Casati S, Castell J, Combes R, Corvi R, Crespi CL, Cunningham ML, Elaut G, Eletti B, Freidig A, Gennari A, Ghersi-Egea JF, Guillouzo A, Hartung T, Hoet P, Ingelman-Sundberg M, Munn S, Janssens W, Ladstetter B, Leahy D, Long A, Meneguz A, Monshouwer M, Morath S, Nagelkerke F, Pelkonen O, Ponti J, Prieto P, Richert L, Sabbioni E, Schaack B, Steiling W, Testai E, Vericat JA, Worth A. (2006). Metabolism: a bottleneck in in vitro toxicological test development. The report and recommendations of ECVAM workshop 54. Altern Lab Anim 34:49–84.
  • Coulter DA, Huguenard JR, Prince DA. (1989). Characterization of ethosuximide reduction of low-threshold calcium current in thalamic neurons. Ann Neurol 25:582–593.
  • Coutu DL, Wu JH, Monette A, Rivard GE, Blostein MD, Galipeau J. (2008). Periostin, a member of a novel family of vitamin K-dependent proteins, is expressed by mesenchymal stromal cells. J Biol Chem 283:17991–18001.
  • Crabb DW, Matsumoto M, Chang D, You M. (2004). Overview of the role of alcohol dehydrogenase and aldehyde dehydrogenase and their variants in the genesis of alcohol-related pathology. Proc Nutr Soc 63:49–63.
  • Crawford M. (1986). Hoechst tests lead EPA to ban herbicide. Science 234:422.
  • Culliton BJ. (1983). Merrell Dow stops marketing bendectin. Science 221:37.
  • Danielsson C, Azarbayjani F, Sköld AC, Sjögren N, Danielsson BR. (2007). Polytherapy with hERG-blocking antiepileptic drugs: increased risk for embryonic cardiac arrhythmia and teratogenicity. Birth Defects Res Part A Clin Mol Teratol 79:595–603.
  • De Backer MD, Loonen I, Verhasselt P, Neefs JM, Luyten WH. (1998). Structure of the human histamine H1 receptor gene. Biochem J 335 (Pt 3):663–670.
  • de Jong E, Louisse J, Verwei M, Blaauboer BJ, van de Sandt JJ, Woutersen RA, Rietjens IM, Piersma AH. (2009). Relative developmental toxicity of glycol ether alkoxy acid metabolites in the embryonic stem cell test as compared with the in vivo potency of their parent compounds. Toxicol Sci 110:117–124.
  • Dembinski J, Heyl W, Steidel K, Hermanns B, Hörnchen H, Schröder W. (1997). The Cantrell-sequence: a result of maternal exposure to aminopropionitriles? Am J Perinatol 14:567–571.
  • Derangeon M, Bozon V, Defamie N, Peineau N, Bourmeyster N, Sarrouilhe D, Argibay JA, Hervé JC. (2010). 5-HT4 and 5-HT2 receptors antagonistically influence gap junctional coupling between rat auricular myocytes. J Mol Cell Cardiol 48:220–229.
  • Desta Z, Wu GM, Morocho AM, Flockhart DA. (2002). The gastroprokinetic and antiemetic drug metoclopramide is a substrate and inhibitor of cytochrome P450 2D6. Drug Metab Dispos 30:336–343.
  • Dorne JL. (2010). Metabolism, variability and risk assessment. Toxicology 268:156–164.
  • Duarte SC, Pena A, Lino CM. (2010). A review on ochratoxin A occurrence and effects of processing of cereal and cereal derived food products. Food Microbiol 27:187–198.
  • Duester G. (1998). Alcohol dehydrogenase as a critical mediator of retinoic acid synthesis from vitamin A in the mouse embryo. J Nutr 128:459S–462S.
  • Duester G. (2008). Retinoic acid synthesis and signaling during early organogenesis. Cell 134:921–931.
  • Dumuis A, Sebben M, Bockaert J. (1989). The gastrointestinal prokinetic benzamide derivatives are agonists at the non-classical 5-HT receptor (5-HT4) positively coupled to adenylate cyclase in neurons. Naunyn Schmiedebergs Arch Pharmacol 340:403–410.
  • Elhassani SB. (1982). The many faces of methylmercury poisoning. J Toxicol Clin Toxicol 19:875–906.
  • Endo A. (1980). Monacolin K, a new hypocholesterolemic agent that specifically inhibits 3-hydroxy-3-methylglutaryl coenzyme A reductase. J Antibiot 33:334–336.
  • European Chemicals Agency. New study inaccurate on the number of test animals for REACH. ECHA/PR/09/11. 30-8-2009. Helsinki, Finland, European Chemicals Agency.
  • Everson RB, Wehr CM, Erexson GL, MacGregor JT. (1988). Association of marginal folate depletion with increased human chromosomal damage in vivo: demonstration by analysis of micronucleated erythrocytes. J Natl Cancer Inst 80:525–529.
  • Farooqui T, Brooks K, Harrold MW, Miller DD, Wallace LJ, Uretsky NJ. (1994). Interaction of permanently charged metoclopramide analogs with D-2 dopamine receptors. Gen Pharmacol 25:1577–1584.
  • Finnell RH, Dansky LV. (1991). Parental epilepsy, anticonvulsant drugs, and reproductive outcome: epidemiologic and experimental findings spanning three decades; 1: Animal studies. Reprod Toxicol 5:281–299.
  • Fischer MH, Welker C, Waisman HA. (1972). Generalized growth retardation in rats induced by prenatal exposure to methylazoxymethyl acetate. Teratology 5:223–232.
  • Fitzgerald WF, Clarkson TW. (1991). Mercury and monomethylmercury: present and future concerns. Environ Health Perspect 96:159–166.
  • Franco B, Meroni G, Parenti G, Levilliers J, Bernard L, Gebbia M, Cox L, Maroteaux P, Sheffield L, Rappold GA, Andria G, Petit C, Ballabio A. (1995). A cluster of sulfatase genes on Xp22.3: mutations in chondrodysplasia punctata (CDPX) and implications for warfarin embryopathy. Cell 81:15–25.
  • Fraser RJ, Bryant L. (2010). Current and future therapeutic prokinetic therapy to improve enteral feed intolerance in the ICU patient. Nutr Clin Pract 25:26–31.
  • Gaylor DW. (2005). Are tumor incidence rates from chronic bioassays telling us what we need to know about carcinogens? Regul Toxicol Pharmacol 41:128–133.
  • Gelineau-van Waes J, Voss KA, Stevens VL, Speer MC, Riley RT. (2009). Maternal fumonisin exposure as a risk factor for neural tube defects. Adv Food Nutr Res 56:145–181.
  • Genschow E, Spielmann H, Scholz G, Pohl I, Seiler A, Clemann N, Bremer S, Becker K. (2004). Validation of the embryonic stem cell test in the international ECVAM validation study on three in vitro embryotoxicity tests. Altern Lab Anim 32:209–244.
  • Genschow E, Spielmann H, Scholz G, Seiler A, Brown N, Piersma A, Brady M, Clemann N, Huuskonen H, Paillard F, Bremer S, Becker K. (2002). The ECVAM international validation study on in vitro embryotoxicity tests: results of the definitive phase and evaluation of prediction models. European Centre for the Validation of Alternative Methods. Altern Lab Anim 30:151–176.
  • Giavini E, Broccia ML, Prati M, Cova D, Rossini L. (1989). Teratogenicity of dinoseb: role of the diet. Bull Environ Contam Toxicol 43:215–219.
  • Gibson JE, Rao KS. (1973). Disposition of 2-sec-butyl-4,6-dinitrophenol (dinoseb) in pregnant mice. Food Cosmet Toxicol 11:45–52.
  • Gilbert SG, Grant-Webster KS. (1995). Neurobehavioral effects of developmental methylmercury exposure. Environ Health Perspect 103 Suppl 6:135–142.
  • Gilboa SM, Strickland MJ, Olshan AF, Werler MM, Correa A; National Birth Defects Prevention Study. (2009). Use of antihistamine medications during early pregnancy and isolated major malformations. Birth Defects Res Part A Clin Mol Teratol 85:137–150.
  • Goldman AS, Yaffe SJ. (1978). Fetal trimethadione syndrome. Teratology 17:103–105.
  • Goldsmith SR. (2005). Current treatments and novel pharmacologic treatments for hyponatremia in congestive heart failure. Am J Cardiol 95:14B–23B.
  • Goldstein JL, Brown MS. (1990). Regulation of the mevalonate pathway. Nature 343:425–430.
  • González-Reyes S, Martínez L, Tovar JA. (2005). Effects of prenatal vitamins A, E, and C on the hypoplastic hearts of fetal rats with diaphragmatic hernia. J Pediatr Surg 40:1269–1274.
  • Gorgojo Martínez JJ, Almodóvar Ruiz F, Donnay Candil S. (2006). Baseline serum folate level may be a predictive factor of weight loss in a morbid-obesity-management programme. Br J Nutr 96, 956–964.
  • Greenhough S, Medine CN, Hay DC. (2010). Pluripotent stem cell derived hepatocyte like cells and their potential in toxicity screening. Toxicology 278:250–255.
  • Greer JJ, Allan DW, Babiuk RP, Lemke RP. (2000). Recent advances in understanding the pathogenesis of nitrofen-induced congenital diaphragmatic hernia. Pediatr Pulmonol 29:394–399.
  • Groebe K, Hayess K, Klemm-Manns M, Schwall G, Wozny W, Steemans M, Peters AK, Sastri C, Jaeckel P, Stegmann W, Zengerling H, Schopf R, Poznanovic S, Stummann TC, Seiler A, Spielmann H, Schrattenholz A. (2010). Protein biomarkers for in vitro testing of embryotoxicity. J Proteome Res 9:5727–5738.
  • Haddad RK, Rabe A, Dumas R. (1972). Comparison of effects of methylazoxymethanol acetate on brain development in different species. Fed Proc 31:1520–1523.
  • Hafizi S, Dahlbäck B. (2006). Gas6 and protein S. Vitamin K-dependent ligands for the Axl receptor tyrosine kinase subfamily. FEBS J 273:5231–5244.
  • Hall JG, Pauli RM, Wilson KM. (1980). Maternal and fetal sequelae of anticoagulation during pregnancy. Am J Med 68:122–140.
  • Halpin RA, Ulm EH, Till AE, Kari PH, Vyas KP, Hunninghake DB, Duggan DE. (1993). Biotransformation of lovastatin. V. Species differences in in vivo metabolite profiles of mouse, rat, dog, and human. Drug Metab Dispos 21:1003–1011.
  • Han X, Lamshöft M, Grobe N, Ren X, Fist AJ, Kutchan TM, Spiteller M, Zenk MH. (2010). The biosynthesis of papaverine proceeds via (S)-reticuline. Phytochemistry 71:1305–1312.
  • Hansen JM, Contreras KM, Harris C. (2005). Methanol, formaldehyde, and sodium formate exposure in rat and mouse conceptuses: a potential role of the visceral yolk sac in embryotoxicity. Birth Defects Res Part A Clin Mol Teratol 73:72–82.
  • Hartung T. (2008). Food for thought. on animal tests. ALTEX 25:3–16.
  • Heath CW Jr. (1966). Cytogenetic observations in vitamin B12 and folate deficiency. Blood 27:800–815.
  • Hendrickx AG, Peterson PE. (1997). Perspectives on the use of the baboon in embryology and teratology research. Hum Reprod Update 3:575–592.
  • Herzel F, Murty AS. (1984). Do carrier solvents enhance the water solubility of hydrophobic compounds? Bull Environ Contam Toxicol 32:53–58.
  • Hettwer M, Reis-Fernandes MA, Iken M, Ott M, Steinberg P, Nau H. (2010). Metabolic activation capacity by primary hepatocytes expands the applicability of the embryonic stem cell test as alternative to experimental animal testing. Reprod Toxicol 30:113–120.
  • Hirokawa Y, Fujiwara I, Suzuki K, Harada H, Yoshikawa T, Yoshida N, Kato S. (2003). Synthesis and structure-affinity relationships of novel N-(1-ethyl-4-methylhexahydro-1,4-diazepin-6-yl)pyridine-3-carboxamides with potent serotonin 5-HT3 and dopamine D2 receptor antagonistic activity. J Med Chem 46:702–715.
  • Ho KM, Power BM. (2010). Benefits and risks of furosemide in acute kidney injury. Anaesthesia 65:283–293.
  • Höfer T, Gerner I, Gundert-Remy U, Liebsch M, Schulte A, Spielmann H, Vogel R, Wettig K. (2004). Animal testing and alternative approaches for the human health risk assessment under the proposed new European chemicals regulation. Arch Toxicol 78:549–564.
  • Holder CL, Siitonen PH, Slikker W Jr, Branscomb CJ, Korfmacher WA, Thompson HC Jr, Cerniglia CE, Gosnell AB, Lay JO Jr. (1990). Metabolism of doxylamine succinate in Fischer 344 rats. Part III: Conjugated urinary and fecal metabolites. J Anal Toxicol 14:247–251.
  • Hornstra IK, Birge S, Starcher B, Bailey AJ, Mecham RP, Shapiro SD. (2003). Lysyl oxidase is required for vascular and diaphragmatic development in mice. J Biol Chem 278:14387–14393.
  • Howe AM, Webster WS. (1990). Exposure of the pregnant rat to warfarin and vitamin K1: an animal model of intraventricular hemorrhage in the fetus. Teratology 42:413–420.
  • Huffman J, Gerber R, Du L. (2010). Recent advancements in the biosynthetic mechanisms for polyketide-derived mycotoxins. Biopolymers 93:764–776.
  • Hurt SS, Smith JM, Hayes AW. (1983). Nitrofen: a review and perspective. Toxicology 29:1–37.
  • ICCVAM. Validation and Regulatory Acceptance of Toxicological Test Methods. NIH PUBLICATION NO: 97–3981. 1997. Research Triangle Park, North Carolina 27709, USA, National Institute of Environmental Health Sciences.
  • Joly D, Rieu P, Méjean A, Gagnadoux MF, Daudon M, Jungers P. (1999). Treatment of cystinuria. Pediatr Nephrol 13:945–950.
  • Joneja MG, Wiley MJ. (1982). Inhibition of beta-aminopropionitrile (beta APN)-induced skeletal teratogenesis by the flavonoid beta-hydroxyethylrutosides (HR) in hamster fetuses. Teratology 26:59–63.
  • Jones DR, Moran JH, Miller GP. (2010). Warfarin and UDP-glucuronosyltransferases: writing a new chapter of metabolism. Drug Metab Rev 42:55–61.
  • Joyce DA. (1989). D-penicillamine pharmacokinetics and pharmacodynamics in man. Pharmacol Ther 42:405–427.
  • Jutel M, Akdis M, Akdis CA. (2009). Histamine, histamine receptors and their role in immune pathology. Clin Exp Allergy 39:1786–1800.
  • Kakita A, Wakabayashi K, Su M, Sakamoto M, Ikuta F, Takahashi H. (2000). Distinct pattern of neuronal degeneration in the fetal rat brain induced by consecutive transplacental administration of methylmercury. Brain Res 859:233–239.
  • Kaminsky LS, Zhang ZY. (1997). Human P450 metabolism of warfarin. Pharmacol Ther 73:67–74.
  • Katagiri R, Kurome M, Teshima Y, Ueta E, Naruse I. (2007). Prevention of ochratoxin A-induced neural tube defects by folic acid in the genetic polydactyly/arhinencephaly mouse, Pdn/Pdn. Congenit Anom (Kyoto) 47:90–96.
  • Kearney PC, Kaufman DD. (1975). Herbicides: Chemistry, Degredation and Mode of Action., Marcel Dekker, Inc., New York.
  • Khalifa M, Drolet B, Daleau P, Lefez C, Gilbert M, Plante S, O’Hara GE, Gleeton O, Hamelin BA, Turgeon J. (1999). Block of potassium currents in guinea pig ventricular myocytes and lengthening of cardiac repolarization in man by the histamine H1 receptor antagonist diphenhydramine. J Pharmacol Exp Ther 288:858–865.
  • Kisby GE, Fry RC, Lasarev MR, Bammler TK, Beyer RP, Churchwell M, Doerge DR, Meira LB, Palmer VS, Ramos-Crawford AL, Ren X, Sullivan RC, Kavanagh TJ, Samson LD, Zarbl H, Spencer PS. (2011). The cycad genotoxin MAM modulates brain cellular pathways involved in neurodegenerative disease and cancer in a DNA damage-linked manner. PLoS ONE 6:e20911.
  • Kitazawa E, Tamura N, Iwabuchi H, Uchiyama M, Muramatsu S, Takahagi H, Tanaka M. (1993). Biotransformation of pravastatin sodium (I). Mechanisms of enzymic transformation and epimerization of an allylic hydroxy group of pravastatin sodium. Biochem Biophys Res Commun 192:597–602.
  • Kling DE, Cavicchio AJ, Sollinger CA, Schnitzer JJ, Kinane TB, Newburg DS. (2010). Nitrofen induces apoptosis independently of retinaldehyde dehydrogenase (RALDH) inhibition. Birth Defects Res B Dev Reprod Toxicol 89:223–232.
  • Kling DE, Schnitzer JJ. (2007). Vitamin A deficiency (VAD), teratogenic, and surgical models of congenital diaphragmatic hernia (CDH). Am J Med Genet C Semin Med Genet 145C:139–157.
  • Knight A. (2007). Animal experiments scrutinised: systematic reviews demonstrate poor human clinical and toxicological utility. ALTEX 24:320–325.
  • Koçtürk S, Oktay G, Güner G, Pekçetin C, Güre A. (2006). Effect of D-penicillamine on rat lung elastin cross-linking during the perinatal period. Cell Biochem Funct 24:167–172.
  • Krämer BK, Bergler T, Stoelcker B, Waldegger S. (2008). Mechanisms of Disease: the kidney-specific chloride channels ClCKA and ClCKB, the Barttin subunit, and their clinical relevance. Nat Clin Pract Nephrol 4:38–46.
  • Kristensen M, Juel C. (2010). Potassium-transporting proteins in skeletal muscle: cellular location and fibre-type differences. Acta Physiol (Oxf) 198:105–123.
  • Kulman JD, Harris JE, Xie L, Davie EW. (2007). Proline-rich Gla protein 2 is a cell-surface vitamin K-dependent protein that binds to the transcriptional coactivator Yes-associated protein. Proc Natl Acad Sci USA 104:8767–8772.
  • Lakics V, Karran EH, Boess FG. (2010). Quantitative comparison of phosphodiesterase mRNA distribution in human brain and peripheral tissues. Neuropharmacology 59:367–374.
  • Lee H, Nagele RG. (1979). Neural tube closure defects caused by papaverine in explanted early chick embryos. Teratology 20:321–331.
  • Lee JH, Han DH. (1995). Maternal and fetal toxicity of methylmercuric chloride administered to pregnant Fischer 344 rats. J Toxicol Environ Health 45:415–425.
  • Lee MH, Cho YS, Han YM. (2007). Simvastatin suppresses self-renewal of mouse embryonic stem cells by inhibiting RhoA geranylgeranylation. Stem Cells 25:1654–1663.
  • Lengner CJ, Gimelbrant AA, Erwin JA, Cheng AW, Guenther MG, Welstead GG, Alagappan R, Frampton GM, Xu P, Muffat J, Santagata S, Powers D, Barrett CB, Young RA, Lee JT, Jaenisch R, Mitalipova M. (2010). Derivation of pre-X inactivation human embryonic stem cells under physiological oxygen concentrations. Cell 141:872–883.
  • Li T, Chang CY, Jin DY, Lin PJ, Khvorova A, Stafford DW. (2004). Identification of the gene for vitamin K epoxide reductase. Nature 427:541–544.
  • Liochev SI, Fridovich I. (2010). Mechanism of the peroxidase activity of Cu, Zn superoxide dismutase. Free Radic Biol Med 48:1565–1569.
  • LoPachin RM, Barber DS. (2006). Synaptic cysteine sulfhydryl groups as targets of electrophilic neurotoxicants. Toxicol Sci 94:240–255.
  • MacGregor JT, Schlegel R, Wehr CM, Alperin P, Ames BN. (1990). Cytogenetic damage induced by folate deficiency in mice is enhanced by caffeine. Proc Natl Acad Sci USA 87:9962–9965.
  • Manson JM. (1986). Mechanism of nitrofen teratogenesis. Environ Health Perspect 70:137–147.
  • Martini C, Trapani L, Narciso L, Marino M, Trentalance A, Pallottini V. (2009). 3-hydroxy 3-methylglutaryl coenzyme A reductase increase is essential for rat muscle differentiation. J Cell Physiol 220:524–530.
  • Marx-Stoelting P, Adriaens E, Ahr HJ, Bremer S, Garthoff B, Gelbke HP, Piersma A, Pellizzer C, Reuter U, Rogiers V, Schenk B, Schwengberg S, Seiler A, Spielmann H, Steemans M, Stedman DB, Vanparys P, Vericat JA, Verwei M, van der Water F, Weimer M, Schwarz M. (2009). A review of the implementation of the embryonic stem cell test (EST). The report and recommendations of an ECVAM/ReProTect Workshop. Altern Lab Anim 37:313–328.
  • Matok I, Gorodischer R, Koren G, Sheiner E, Wiznitzer A, Levy A. (2009). The safety of metoclopramide use in the first trimester of pregnancy. N Engl J Med 360:2528–2535.
  • Matsumoto M, Fujii S, Hirose A, Ema M. (2010). Prenatal developmental toxicity of gavage or feeding doses of 2-sec-butyl-4,6-dinitrophenol in rats. Reprod Toxicol 29:292–297.
  • Matsumoto M, Poncipe C, Ema M. (2008). Review of developmental toxicity of nitrophenolic herbicide dinoseb, 2-sec-butyl-4,6-dinitrophenol. Reprod Toxicol 25:327–334.
  • McBride WG, Hicks LJ. (1987). Acetylcholine and choline levels in rabbit fetuses exposed to anticholinergics. Int J Dev Neurosci 5:117–125.
  • Mendelsohn C, Lohnes D, Décimo D, Lufkin T, LeMeur M, Chambon P, Mark M. (1994). Function of the retinoic acid receptors (RARs) during development (II). Multiple abnormalities at various stages of organogenesis in RAR double mutants. Development 120:2749–2771.
  • Mensch J, Oyarzabal J, Mackie C, Augustijns P. (2009). In vivo, in vitro and in silico methods for small molecule transfer across the BBB. J Pharm Sci 98:4429–4468.
  • Mey J, Babiuk RP, Clugston R, Zhang W, Greer JJ. (2003). Retinal dehydrogenase-2 is inhibited by compounds that induce congenital diaphragmatic hernias in rodents. Am J Pathol 162:673–679.
  • Minsker DH, MacDonald JS, Robertson RT, Bokelman DL. (1983). Mevalonate supplementation in pregnant rats suppresses the teratogenicity of mevinolinic acid, an inhibitor of 3-hydroxy-3-methylglutaryl-coenzyme a reductase. Teratology 28:449–456.
  • Miskon A, Mahara A, Uyama H, Yamaoka T. (2010). A suspension induction for myocardial differentiation of rat mesenchymal stem cells on various extracellular matrix proteins. Tissue Eng Part C Methods 16:979–987.
  • Mizuta E, Shirai M, Arakawa K, Hidaka K, Miake J, Ninomiya H, Kato M, Shigemasa C, Shirayoshi Y, Hisatome I, Morisaki T. (2010). Different distribution of Cav3.2 and Cav3.1 transcripts encoding T-type Ca(2+) channels in the embryonic heart of mice. Biomed Res 31:301–305.
  • Molnar J, Fong KS, He QP, Hayashi K, Kim Y, Fong SF, Fogelgren B, Szauter KM, Mink M, Csiszar K. (2003). Structural and functional diversity of lysyl oxidase and the LOX-like proteins. Biochim Biophys Acta 1647:220–224.
  • Moore H, Jentsch JD, Ghajarnia M, Geyer MA, Grace AA. (2006). A neurobehavioral systems analysis of adult rats exposed to methylazoxymethanol acetate on E17: implications for the neuropathology of schizophrenia. Biol Psychiatry 60:253–264.
  • Moraes AP, Schwarz A, Spinosa HS, Florio JC, Bernardi MM. (2004). Maternal exposure to diphenhydramine during the fetal period in rats: effects on physical and neurobehavioral development and on neurochemical parameters. Neurotoxicol Teratol 26:681–692.
  • Moran D, Rice RW. (1976). Action of papaverine and ionophore A23187 on neurulation. Nature 261:497–499.
  • Moreland DE. (1999). Biochemical mechanisms of action of herbicides and the impact of biotechnology on the development of herbicides. J Pesticide Sci 24, 299–307.
  • Morgan RW, Hoffmann GR. (1983). Cycasin and its mutagenic metabolites. Mutat Res 114:19–58.
  • Morris AJ, Malbon CC. (1999). Physiological regulation of G protein-linked signaling. Physiol Rev 79:1373–1430.
  • Mosmann T. (1983). Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65:55–63.
  • Murshed M, Schinke T, McKee MD, Karsenty G. (2004). Extracellular matrix mineralization is regulated locally; different roles of two gla-containing proteins. J Cell Biol 165:625–630.
  • Myint B. (1984). D-penicillamine-induced cleft palate in mice. Teratology 30:333–340.
  • Nagasawa HT, Shirota FN, Matsumoto H. (1972). Decomposition of methylazoxymethanol, the aglycone of cycasin, in D 2 O. Nature 236:234–235.
  • Nakatsuka T, Fujikake N, Hasebe M, Ikeda H. (1993). Effects of sodium bicarbonate and ammonium chloride on the incidence of furosemide-induced fetal skeletal anomaly, wavy rib, in rats. Teratology 48:139–147.
  • Napoletano M, Pennino D, Izzo G, de Maria S, Ottaviano R, Ricciardi M, Mancini R, Schiattarella A, Farina E, Metafora S, Cartenì M, Ritieni A, Minucci S, Morelli F. (2010). Ochratoxin A induces craniofacial malformation in mice acting on Dlx5 gene expression. Front Biosci (Elite Ed) 2:133–142.
  • National Research Council. Toxicity Testing in the 21st Century: A Vision and a Strategy. (2007). Washington, DC, National Academy Press.
  • Newland MC, Paletz EM, Reed MN. (2008). Methylmercury and nutrition: adult effects of fetal exposure in experimental models. Neurotoxicology 29:783–801.
  • Noble BR, Babiuk RP, Clugston RD, Underhill TM, Sun H, Kawaguchi R, Walfish PG, Blomhoff R, Gundersen TE, Greer JJ. (2007). Mechanisms of action of the congenital diaphragmatic hernia-inducing teratogen nitrofen. Am J Physiol Lung Cell Mol Physiol 293:L1079–L1087.
  • Notman J, Tan QH, Zedeck MS. (1982). Inhibition of methylazoxymethanol-induced intestinal tumors in the rat by pyrazole with paradoxical effects on skin and kidney. Cancer Res 42:1774–1780.
  • O’Brien E, Dietrich DR. (2005). Ochratoxin A: the continuing enigma. Crit Rev Toxicol 35:33–60.
  • OECD. Final report of the OECD Workshop on Harmonisation of Validation and Acceptance Criteria for Alternative Toxicological Test Methods. 1996. Paris, France, Organisation for Economic Co-operation and Development.
  • Paquette JA, Kumpf SW, Streck RD, Thomson JJ, Chapin RE, Stedman DB. (2008). Assessment of the Embryonic Stem Cell Test and application and use in the pharmaceutical industry. Birth Defects Res B Dev Reprod Toxicol 83:104–111.
  • Parenti G, Meroni G, Ballabio A. (1997). The sulfatase gene family. Curr Opin Genet Dev 7:386–391.
  • Pasutto F, Sticht H, Hammersen G, Gillessen-Kaesbach G, Fitzpatrick DR, Nürnberg G, Brasch F, Schirmer-Zimmermann H, Tolmie JL, Chitayat D, Houge G, Fernández-Martínez L, Keating S, Mortier G, Hennekam RC, von der Wense A, Slavotinek A, Meinecke P, Bitoun P, Becker C, Nürnberg P, Reis A, Rauch A. (2007). Mutations in STRA6 cause a broad spectrum of malformations including anophthalmia, congenital heart defects, diaphragmatic hernia, alveolar capillary dysplasia, lung hypoplasia, and mental retardation. Am J Hum Genet 80:550–560.
  • Patil RD, Dwivedi P, Sharma AK. (2006). Critical period and minimum single oral dose of ochratoxin A for inducing developmental toxicity in pregnant Wistar rats. Reprod Toxicol 22:679–687.
  • Pazos P, Pellizzer C, Stummann TC, Hareng L, Bremer S. (2010). The test chemical selection procedure of the European Centre for the Validation of Alternative Methods for the EU Project ReProTect. Reprod Toxicol 30:161–199.
  • Peters AK, Steemans M, Hansen E, Mesens N, Verheyen GR, Vanparys P. (2008a). Evaluation of the embryotoxic potency of compounds in a newly revised high throughput embryonic stem cell test. Toxicol Sci 105:342–350.
  • Peters AK, Wouwer GV, Weyn B, Verheyen GR, Vanparys P, Gompel JV. (2008b). Automated analysis of contractility in the embryonic stem cell test, a novel approach to assess embryotoxicity. Toxicol In Vitro 22:1948–1956.
  • Pfohl-Leszkowicz A. (2009). Ochratoxin A and aristolochic acid involvement in nephropathies and associated urothelial tract tumours. Arh Hig Rada Toksikol 60:465–483.
  • Pinter R, Hogge WA, McPherson E. (2004). Infant with severe penicillamine embryopathy born to a woman with Wilson disease. Am J Med Genet A 128A:294–298.
  • Preache MM, Gibson JE. (1975). Effects in mice of high and low environmental temperature on the maternal and fetal toxicity of 2-sec-butyl-4,6-dinitrophenol (dinoseb) and on disposition of [14C]-dinoseb(12). Teratology 12:147–156.
  • Priebe HJ. (2007). Aneurysmal subarachnoid haemorrhage and the anaesthetist. Br J Anaesth 99:102–118.
  • Quion JA, Jones PH. (1994). Clinical pharmacokinetics of pravastatin. Clin Pharmacokinet 27:94–103.
  • Reidy JA, Zhou X, Chen AT. (1983). Folic acid and chromosome breakage. I. Implications for genotoxicity studies. Mutat Res 122:217–221.
  • Riebeling C, Pirow R, Becker K, Buesen R, Eikel D, Kaltenhäuser J, Meyer F, Nau H, Slawik B, Visan A, Volland J, Spielmann H, Luch A, Seiler A. (2011a). The embryonic stem cell test as tool to assess structure-dependent teratogenicity: the case of valproic acid. Toxicol Sci 120:360–370.
  • Riebeling C, Schlechter K, Buesen R, Spielmann H, Luch A, Seiler A. (2011b). Defined culture medium for stem cell differentiation: applicability of serum-free conditions in the mouse embryonic stem cell test. Toxicol In Vitro 25:914–921.
  • Ringot D, Chango A, Schneider YJ, Larondelle Y. (2006). Toxicokinetics and toxicodynamics of ochratoxin A, an update. Chem Biol Interact 159:18–46.
  • Rosa FW. (1986). Teratogen update: penicillamine. Teratology 33:127–131.
  • Rovida C, Hartung T. (2009). Re-evaluation of animal numbers and costs for in vivo tests to accomplish REACH legislation requirements for chemicals - a report by the transatlantic think tank for toxicology (t(4)). ALTEX 26:187–208.
  • Rumora L, Grubisic TZ. (2009). A journey through mitogen-activated protein kinase and ochratoxin A interactions. Arh Hig Rada Toksikol 60:449–456.
  • Russell JM. (2000). Sodium-potassium-chloride cotransport. Physiol Rev 80:211–276.
  • Sakamoto M, Murata K, Tsuruta K, Miyamoto K, Akagi H. (2010). Retrospective study on temporal and regional variations of methylmercury concentrations in preserved umbilical cords collected from inhabitants of the Minamata area, Japan. Ecotoxicol Environ Saf 73:1144–1149.
  • Sanger GJ. (2009). Translating 5-HT receptor pharmacology. Neurogastroenterol Motil 21:1235–1238.
  • Schaefer L, Ballabio A, Zoghbi HY. (1996). Cloning and characterization of a putative human holocytochrome c-type synthetase gene (HCCS) isolated from the critical region for microphthalmia with linear skin defects (MLS). Genomics 34:166–172.
  • Schardein JL, Keller KA. (1989). Potential human developmental toxicants and the role of animal testing in their identification and characterization. Crit Rev Toxicol 19:251–339.
  • Schenk B, Weimer M, Bremer S, van der Burg B, Cortvrindt R, Freyberger A, Lazzari G, Pellizzer C, Piersma A, Schäfer WR, Seiler A, Witters H, Schwarz M. (2010). The ReProTect Feasibility Study, a novel comprehensive in vitro approach to detect reproductive toxicants. Reprod Toxicol 30:200–218.
  • Schmidt S, Gonzalez D, Derendorf H. (2010). Significance of protein binding in pharmacokinetics and pharmacodynamics. J Pharm Sci 99:1107–1122.
  • Schneider D, Wink M, Sporer F, Lounibos P. (2002). Cycads: their evolution, toxins, herbivores and insect pollinators. Naturwissenschaften 89:281–294.
  • Scholz G, Genschow E, Pohl I, Bremer S, Paparella M, Raabe H, Southee J, Spielmann H. (1999). Prevalidation of the Embryonic Stem Cell Test (EST)-A New In Vitro Embryotoxicity Test. Toxicol In Vitro 13:675–681.
  • Seiler A, Visan A, Buesen R, Genschow E, Spielmann H. (2004). Improvement of an in vitro stem cell assay for developmental toxicity: the use of molecular endpoints in the embryonic stem cell test. Reprod Toxicol 18:231–240.
  • Seiler AE, Buesen R, Visan A, Spielmann H. (2006). Use of murine embryonic stem cells in embryotoxicity assays: the embryonic stem cell test. Methods Mol Biol 329:371–395.
  • Seiler AE, Spielmann H. (2011). The validated embryonic stem cell test to predict embryotoxicity in vitro. Nat Protoc 6:961–978.
  • Sharma A, Hamelin BA. (2003). Classic histamine H1 receptor antagonists: a critical review of their metabolic and pharmacokinetic fate from a bird’s eye view. Curr Drug Metab 4:105–129.
  • Sievert HW, Lipton SH, Strong FM. (1960). Quantitative determination of cyanoacetic acid as an enzymic product of beta-aminopropionitrile. Arch Biochem Biophys 86:311–316.
  • Sinicropi MS, Amantea D, Caruso A, Saturnino C. (2010). Chemical and biological properties of toxic metals and use of chelating agents for the pharmacological treatment of metal poisoning. Arch Toxicol 84:501–520.
  • Siuciak JA, Chapin DS, Harms JF, Lebel LA, McCarthy SA, Chambers L, Shrikhande A, Wong S, Menniti FS, Schmidt CJ. (2006). Inhibition of the striatum-enriched phosphodiesterase PDE10A: a novel approach to the treatment of psychosis. Neuropharmacology 51:386–396.
  • Smedley MJ, Stanisstreet M. (1986). Calcium and neurulation in mammalian embryos. II. Effects of cytoskeletal inhibitors and calcium antagonists on the neural folds of rat embryos. J Embryol Exp Morphol 93:167–178.
  • Smith MB, Feldman W. (1993). Over-the-counter cold medications. A critical review of clinical trials between 1950 and 1991. JAMA 269:2258–2263.
  • Spielmann H, Pohl I, Döring B, Liebsch M, Moldenhauer F. (1997). The Embryonic Stem cell Test, an in vitro embryotoxicity test using two permanent mouse cell lines: 3T3 fibroblasts and embryonic stem cells. In Vitro Mol Toxicol J Basic Appl Res 10, 119–127.
  • Stolper G, Klausner M, Sheasgreen J, Hayden P. (2005). Development of an in vitro blood-brain barrier model for brain disposition screening of pharmaceuticals. The Toxicologist 84, 257.
  • Stummann TC, Hareng L, Bremer S. (2007). Embryotoxicity hazard assessment of methylmercury and chromium using embryonic stem cells. Toxicology 242:130–143.
  • Suarez-Almazor ME, Spooner C, Belseck E. (2000). Penicillamine for treating rheumatoid arthritis. Cochrane Database Syst Rev (4): CD001460.
  • Sutherland GR. (1979). Heritable fragile sites on human chromosomes I. Factors affecting expression in lymphocyte culture. Am J Hum Genet 31:125–135.
  • Taglialatela M, Timmerman H, Annunziato L. (2000). Cardiotoxic potential and CNS effects of first-generation antihistamines. Trends Pharmacol Sci 21:52–56.
  • Taguchi N, Rubin ET, Hosokawa A, Choi J, Ying AY, Moretti ME, Koren G, Ito S. (2008). Prenatal exposure to HMG-CoA reductase inhibitors: effects on fetal and neonatal outcomes. Reprod Toxicol 26:175–177.
  • Takahashi N, Chernavvsky DR, Gomez RA, Igarashi P, Gitelman HJ, Smithies O. (2000). Uncompensated polyuria in a mouse model of Bartter’s syndrome. Proc Natl Acad Sci USA 97:5434–5439.
  • Takai Y, Sasaki T, Matozaki T. (2001). Small GTP-binding proteins. Physiol Rev 81:153–208.
  • Tanaka E, Ishikawa A, Abei M, Kobayashi S. (1996). Trimethadione as a probe drug to estimate hepatic oxidizing capacity in humans. Comp Biochem Physiol C, Pharmacol Toxicol Endocrinol 115:211–216.
  • Tang SS, Trackman PC, Kagan HM. (1983). Reaction of aortic lysyl oxidase with beta-aminopropionitrile. J Biol Chem 258:4331–4338.
  • Tarín JJ, Ten J, Vendrell FJ, Cano A. (1998). Dithiothreitol prevents age-associated decrease in oocyte/conceptus viability in vitro. Hum Reprod 13:381–386.
  • Theunissen PT, Schulpen SH, van Dartel DA, Hermsen SA, van Schooten FJ, Piersma AH. (2010). An abbreviated protocol for multilineage neural differentiation of murine embryonic stem cells and its perturbation by methyl mercury. Reprod Toxicol 29:383–392.
  • Timmerman H. (1999). Why are non-sedating antihistamines non-sedating? Clin Exp Allergy 29 Suppl 3:13–18.
  • Tong S, Yao Q, Wan Y, Zhou J, Shu M, Zhong L, Li Y, Zhang Q, Yindai J, Song Z. (2009). Development of functional I f channels in mMSCs after transfection with mHCN4: effects on cell morphology and mechanical activity in vitro. Cardiology 112:114–121.
  • Tonini M, Cipollina L, Poluzzi E, Crema F, Corazza GR, De Ponti F. (2004). Review article: clinical implications of enteric and central D2 receptor blockade by antidopaminergic gastrointestinal prokinetics. Aliment Pharmacol Ther 19:379–390.
  • Torres Pazmiño DE, Winkler M, Glieder A, Fraaije MW. (2010). Monooxygenases as biocatalysts: Classification, mechanistic aspects and biotechnological applications. J Biotechnol 146:9–24.
  • Tsujita Y, Kuroda M, Shimada Y, Tanzawa K, Arai M, Kaneko I, Tanaka M, Masuda H, Tarumi C, Watanabe Y. (1986). CS-514, a competitive inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase: tissue-selective inhibition of sterol synthesis and hypolipidemic effect on various animal species. Biochim Biophys Acta 877:50–60.
  • Turpeinen M, Ghiciuc C, Opritoui M, Tursas L, Pelkonen O, Pasanen M. (2007). Predictive value of animal models for human cytochrome P450 (CYP)-mediated metabolism: a comparative study in vitro. Xenobiotica 37:1367–1377.
  • Tyl RW, Price CJ, Marr MC, Kimmel CA. (1988). Developmental toxicity evaluation of Bendectin in CD rats. Teratology 37:539–552.
  • Uibel F, Mühleisen A, Köhle C, Weimer M, Stummann TC, Bremer S, Schwarz M. (2010). ReProGlo: a new stem cell-based reporter assay aimed to predict embryotoxic potential of drugs and chemicals. Reprod Toxicol 30:103–112.
  • Ullrich SM, Tanton TW, Abdrashitova SA. (2001). Mercury in the aquatic environment: A review of factors affecting methylation. Crit Rev Env Sci Tec 31, 241–293.
  • Uriu-Adams JY, Scherr RE, Lanoue L, Keen CL. (2010). Influence of copper on early development: prenatal and postnatal considerations. Biofactors 36:136–152.
  • Vacher H, Mohapatra DP, Trimmer JS. (2008). Localization and targeting of voltage-dependent ion channels in mammalian central neurons. Physiol Rev 88:1407–1447.
  • van Assche CJ, Carles PM. Photosystem-II Inhibiting Chemicals - Molecular Interaction Between Inhibitors and A Common Target. ACS Symposium Series 181, 1-21. 11-2-1982. Washington, DC, USA, American Chemical Society. Biochemical Responses Induced by Herbicides. Moreland DE.
  • van Dartel DA, Pennings JL, de la Fonteyne LJ, van Herwijnen MH, van Delft JH, van Schooten FJ, Piersma AH. (2010). Monitoring developmental toxicity in the embryonic stem cell test using differential gene expression of differentiation-related genes. Toxicol Sci 116:130–139.
  • van der Valk, Brunner D, De SK, Fex SA, Honegger P, Knudsen LE, Lindl T, Noraberg J, Price A, Scarino ML, Gstraunthaler G. (2010). Optimization of chemically defined cell culture media--Replacing fetal bovine serum in mammalian in vitro methods. Toxicol In Vitro 24, 1053–1063.
  • van Driel D, Wesseling J, Sauer PJ, Touwen BC, van der Veer E, Heymans HS. (2002). Teratogen update: fetal effects after in utero exposure to coumarins overview of cases, follow-up findings, and pathogenesis. Teratology 66:127–140.
  • Verwei M, van Burgsteden JA, Krul CA, van de Sandt JJ, Freidig AP. (2006). Prediction of in vivo embryotoxic effect levels with a combination of in vitro studies and PBPK modelling. Toxicol Lett 165:79–87.
  • Viant MR, Pincetich CA, Hinton DE, Tjeerdema RS. (2006). Toxic actions of dinoseb in medaka (Oryzias latipes) embryos as determined by in vivo 31P NMR, HPLC-UV and 1H NMR metabolomics. Aquat Toxicol 76:329–342.
  • Voisin EM, Ruthsatz M, Collins JM, Hoyle PC. (1990). Extrapolation of animal toxicity to humans: interspecies comparisons in drug development. Regul Toxicol Pharmacol 12:107–116.
  • Wallin R, Hutson SM. (2004). Warfarin and the vitamin K-dependent gamma-carboxylation system. Trends Mol Med 10:299–302.
  • Walton K, Dorne JLCM, Renwick AG. (2001). Default factors for interspecies differences in the major routes of xenobiotic elimination. Human Ecol. Risk Assessment 7:181–201.
  • Wardrop D, Keeling D. (2008). The story of the discovery of heparin and warfarin. Br J Haematol 141:757–763.
  • Waterman RE. (1979). Scanning electron microscope studies of central nervous system development. Birth Defects Orig Artic Ser 15:55–77.
  • Watterson K, Sankala H, Milstien S, Spiegel S. (2003). Pleiotropic actions of sphingosine-1-phosphate. Prog Lipid Res 42:344–357.
  • Whitlow S, Bürgin H, Clemann N. (2007). The embryonic stem cell test for the early selection of pharmaceutical compounds. ALTEX 24:3–7.
  • Wiley MJ, Joneja MG. (1976). The teratogenic effects of beta-aminopropionitrile in hamsters. Teratology 14:43–52.
  • Wiley MJ, Joneja MG. (1978). Neural tube lesions in the offspring of hamsters given single oral doses of lathyrogens early in gestation. Acta Anat (Basel) 100:347–353.
  • Williams DP, Antoine DJ, Butler PJ, Jones R, Randle L, Payne A, Howard M, Gardner I, Blagg J, Park BK. (2007). The metabolism and toxicity of furosemide in the Wistar rat and CD-1 mouse: a chemical and biochemical definition of the toxicophore. J Pharmacol Exp Ther 322:1208–1220.
  • Wilson JG, Roth CB, Warkany J. (1953). An analysis of the syndrome of malformations induced by maternal vitamin A deficiency. Effects of restoration of vitamin A at various times during gestation. Am J Anat 92:189–217.
  • Yasuda Y, Datu AR, Hirata S, Fujimoto T. (1985). Characteristics of growth and palatal shelf development in ICR mice after exposure to methylmercury. Teratology 32:273–286.
  • zur Nieden NI, Davis LA, Rancourt DE. (2010). Comparing three novel endpoints for developmental osteotoxicity in the embryonic stem cell test. Toxicol Appl Pharmacol 247:91–97.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.